 |
|
News & Publications |
|
 |
|
 |
 |
 |
 |
|
|||
| Newsroom | |
News Archive | |
Publications | Contact Us for Experts |  |
|
|
|
|
|||||
News from: |
2008 | | | 2007 | | | 2006 | | | 2005 | | | 2004 | | | 2003 | | | 2002 | | | 2001 | | |  Feed |
 |
NEWS
RELEASE
MARCH 9, 2007 |
|
| Penn Study Suggests Test for Tumor Suppressor p53 Is Needed to Prescreen Patients for Blood Cancer Drugs | ||
| Back to Article | ||
| Image 1 | ||
| Green staining depicts tumor cells dying after treatment with proteasome inhibitors. In the left panel, the tumor lacks p53, and only a fraction of the cells are killed. In the right panel, the tumor produces p53, resulting in massive cell death. Image Credit: Andrei Thomas-Tikhonenko, PhD, University of Pennsylvania School of Medicine; Blood. Download high-resolution version (512 KB, JPEG, 300 DPI) |
||
 |
||
|
About UPHS Contact Us Site Map Privacy Statement Legal Disclaimer Terms of Use |
|
The University of Pennsylvania Health System,
Philadelphia, PA 1-800-789-PENN ©
2008, The Trustees of the University of Pennsylvania |